This report contains forward-looking statements. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. Forward-looking statements made in a quarterly report on Form 10-Q includes statements about:
º our plans to identify and acquire products that we believe will be prospective for acquisition and development; º our intention to develop to the clinical stage a new technology for regeneration of functional insulin- producing cells, thus enabling normal glucose regulated insulin secretion, via cell therapy; º our belief that our treatment seems to be safer than other options; º our belief that our major competitive advantage is in our cell transformation technology; º our marketing plan; º our plans to hire industry experts and expand our management team; º our belief that Diabetes Mellitus will be one of the most challenging health problems in the 21st century and will have staggering health, societal and economic impact; º our beliefs regarding the future of our competitors; º our expectation that the demand for our products will eventually increase; and º our expectation that we will be able to raise capital when we need it.
These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled "Risk Factors" and the risks set out below, any of which may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks include, by way of example and not in limitation:
º general economic and business conditions; º substantial doubt about our ability to continue as a going concern; º we may need to raise additional funds in the future which may not be available on acceptable terms or at all; º if we are unable to successfully recruit and retain qualified personnel, we may not be able to continue our operation; º we may not be able to successfully implement our business plan; º conditions in
Israeland the surrounding Middle Eastmay materially adversely affect our subsidiary's operations and personnel; º the ability of our subsidiary to pay dividends is subject to limitations under Israeli law and dividends paid and loans extended by our subsidiary may be subject to taxes; º THM may cancel the License Agreement; º if we are unable to successfully acquire, develop or commercialize new products, our operating results will suffer; º our expenditures may not result in commercially successful products; º third parties may claim that we infringe their proprietary rights and may prevent us from manufacturing and selling some of our products; º extensive industry regulation has had, and will continue to have, a significant impact on our business, especially our product development, manufacturing and distribution capabilities; and º other factors discussed under the section entitled "Risk Factors".